Identification of high‐risk stage II and stage III colorectal cancer by analysis of MMP‐21 expression
- 7 June 2011
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 104 (7) , 787-791
Abstract
Background The expression of matrix metalloproteinase‐21 (MMP‐21) has been shown to be elevated in some solid tumor and thought to enhance tumor invasion and metastasis ability. In the present study, we investigated the expression of MMP‐21 and its association with prognosis in stage II and III colorectal cancer. Methods MMP‐21 expression was investigated in 286 cases of colorectal cancer by immunohistochemistry assay. Statistical analysis was utilized to evaluate the association of MMP‐21 expression with clinicopathological characters and overall survival of patients with stage II and III colorectal cancer. Results MMP‐21 expression was significantly higher in colorectal cancer, compared with that in normal epithelial tissue. And it also correlated with tumor invasion, lymph node metastasis, and distant metastasis of colorectal cancer. MMP‐21 was also proved to be an independent prognostic factor in patients with stage II as well as stage III colorectal cancer. However, no correlations between MMP‐21 expression and patients' age, sex, tumor location, or differentiation status were detected. Conclusion These results suggested the potential role of MMP‐21 in the invasion and metastasis process of human colorectal cancer. It could also be a novel molecular marker to predict prognosis of patients with stage II and stage III colorectal cancer. J. Surg. Oncol. 2011; 104:787–791.Keywords
This publication has 32 references indexed in Scilit:
- Expression of MMP-10, MMP-21, MMP-26, and MMP-28 in Merkel cell carcinomaVirchows Archiv, 2009
- Worldwide Variations in Colorectal CancerCA: A Cancer Journal for Clinicians, 2009
- No Association of MMP-7, MMP-8, and MMP-21 Polymorphisms with the Risk of Hepatocellular Carcinoma in a Chinese PopulationCancer Epidemiology, Biomarkers & Prevention, 2008
- Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinomaLaboratory Investigation, 2007
- Prognostic significance of matrix metalloproteinases‐1, ‐2, ‐7 and ‐13 and tissue inhibitors of metalloproteinases‐1, ‐2, ‐3 and ‐4 in colorectal cancerInternational Journal of Cancer, 2007
- Matrix Metalloproteinase-21 Is Expressed Epithelially During Development and in Cancer and Is Up-Regulated by Transforming Growth Factor-β1 in KeratinocytesLaboratory Investigation, 2003
- The structure and regulation of the human and mouse matrix metalloproteinase-21 gene and proteinBiochemical Journal, 2003
- Matrix metalloproteinasesEuropean Journal of Cancer, 2000
- Matrix metalloproteinasesBritish Journal of Surgery, 1997
- Matrix metalloproteinasesBritish Journal of Surgery, 1997